# Plerixafor

NDC: 72205-249
Generic name: Plerixafor
Labeler / Manufacturer: Novadoz Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20230725

FDA application: ANDA211901

## Active ingredients

- PLERIXAFOR: 24 mg/1.2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72205-249"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72205-249
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f26effc5-2a22-441f-91ac-e131ee1c9886
